No black box warning on record for Prochlorperazine Maleate

As of the latest FDA labeling reviewed, Prochlorperazine Maleate (PROCHLORPERAZINE MALEATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Prochlorperazine Maleate medicine page for the complete safety profile.

Other warnings & precautions

Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Prochlorperazine maleate is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING). The extrapyramidal symptoms which can occur secondary to prochlorperazine may be confus

No black box warning on record for Prochlorperazine Maleate

Other warnings & precautions

Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Prochlorperazine maleate is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING). The extrapyramidal symptoms which can occur secondary to prochlorperazine may be confus

Prochlorperazine Maleate Black Box Warning

No black box warning on record for Prochlorperazine Maleate

Other warnings & precautions

Prochlorperazine Maleate Black Box Warning

No black box warning on record for Prochlorperazine Maleate

Other warnings & precautions